CHEK2 is a tumor suppressor gene associated with a moderately increased cumulative lifetime breast cancer (BC) risk (1.4- to 3-fold; Cybulski et al. 2011; Meijers-Heijboer et al. 2002; Weischer et al. 2008). This evidence concerns the gene CHEK2 and breast carcinoma.